Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Paragon Bioservices has received a JVAP-CBMS contract from the Department of Defense (DoD) for vaccine development and GMP manufacturing of the 'VEE Replicon Particle Trivalent Filovirus Vaccine.'
Subscribe to our email newsletter
The initial phase of the contract is believed to be worth $15m.
Paragon will develop a large-scale process suitable for cGMP manufacturing, under the contract.
Previously in October 2010, the US Army awarded a contract to Paragon which involves process development and scale-up production to support the efficacy and potency of filovirus vaccine candidates against deadly Ebola and Marburg viruses.
Paragon Bioservices is a contract research and GMP manufacturing organization with an emphasis on the development and manufacturing of biopharmaceuticals for research or clinical trials.